Right now, Wegovy and Ozempic are the most widely used and recognized weight loss drugs, driven by strong clinical results and high public awareness
A large cohort study of women with T2D revealed that short-term use of GLP-1RAs and dipeptidyl peptidase-4 (DPP4) inhibitors was not associated with reduced EC risk compared with sulfonylureas
Rapamycin, metformin, and NAD+ precursors have robust evidence in animal models demonstrating lifespan extension and healthspan improvements
Uncommon Ozempic side effects While typical side effects skew on the milder side, Novo Nordisk lists a number of Ozempic side effects, including possible thyroid tumors, thyroid cancer, and vision changes
R.ConradM
MET signalling: principles and functions in development, organ regeneration and cancer